Scynexis (SCYX) Other Accumulated Expenses (2016 - 2026)
Scynexis (SCYX) reported Other Accumulated Expenses of $809000.0 for Q1 2026, down 14.12% on a YoY basis from $942000.0 in Q1 2025, and up 69.25% quarter-over-quarter from $478000.0 in Q4 2025.
Scynexis (SCYX) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
Scynexis has reported Other Accumulated Expenses for 11 years, with the latest figure at $809000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses fell 14.12% year-over-year to $809000.0; the trailing twelve-month figure through Mar 2026 stood at $809000.0 (down 14.12% YoY), and the FY2025 full-year result was $478000.0, down 39.34% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $809000.0, up from $478000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $1.3 million in Q4 2022, with the low at $174000.0 in Q1 2022.
- Historically, Other Accumulated Expenses has averaged $767857.1 across 5 years, with a median of $798500.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses sank 83.49% — and 2025, when it jumped 72.53%.
- Scynexis' Other Accumulated Expenses stood at $1.3 million in 2022, then decreased by 20.79% to $1.0 million in 2023, then fell by 24.23% to $788000.0 in 2024, then sank by 39.34% to $478000.0 in 2025, then jumped by 69.25% to $809000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $809000.0 (Q1 2026), $478000.0 (Q4 2025), and $895000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 809,000.00 |
| Dec 31, 2025 | 478,000.00 |
| Sep 30, 2025 | 895,000.00 |
| Jun 30, 2025 | 757,000.00 |
| Mar 31, 2025 | 942,000.00 |
| Dec 31, 2024 | 788,000.00 |
| Sep 30, 2024 | 969,000.00 |
| Jun 30, 2024 | 862,000.00 |
| Mar 31, 2024 | 546,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 720,000.00 |
| Jun 30, 2022 | 457,000.00 |
| Mar 31, 2022 | 174,000.00 |
| Sep 30, 2021 | 2.15 Mn |
| Jun 30, 2021 | 1.39 Mn |
| Mar 31, 2021 | 1.05 Mn |
| Dec 31, 2020 | 960,000.00 |
| Sep 30, 2020 | 937,000.00 |
| Jun 30, 2020 | 974,000.00 |